A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Clinical trial NCT07214753 · RECRUITING

Trial details

NCT number: NCT07214753
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2025-12-20
Primary completion: 2028-12-31
Enrollment: 335

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.